Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
North America Organoids Market Forecast to 2030 - Increasing Demand for Tumor Modeling and Biobanking and Advancements in Personalized Medicine Propelling Organoid Market Growth | ||
By: PR Newswire Association LLC. - 12 Feb 2024 | Back to overview list |
|
DUBLIN, Feb. 12, 2024 /PRNewswire/ -- The "North America Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type" report has been added to ResearchAndMarkets.com's offering. The North America organoids market is poised for a substantial growth forecasted from US$ 1.125 billion in 2022 to a staggering US$ 5.35 billion by 2030. This sharp incline, estimated at a CAGR of 21.5% during the forecast period, can be attributed to several factors, including the increasing adoption of personalized medicine and advancements in stem cell research. This comprehensive analysis of the market offers in-depth insights into the organ type, application, source, and various types encapsulating the North America organoids market. Advancements in Personalized Medicine Propelling Organoid Market Growth One significant driver behind the vigorous North America organoids market growth is the rising inclination towards personalized or precision medicine. This cutting-edge medical model enhances drug development and treatment strategies, tailored to individual patient profiles based on genetic information and disease susceptibility. The role of organoids in revolutionizing personalized drug therapies plays a fundamental part in this sector's expansion, creating a robust platform for patient-specific treatment protocols. Key Market Segment Highlights The extensive report illuminates the diverse segments within the organoid market:
A thoughtful analysis of these segments provides valuable insights into the marketplace, guiding stakeholder decisions and spotlighting growth opportunities. Regional Analysis: The United States Takes the Lead The US continues to dominate the North American market, powered by a significant increase in the number of patients with chronic and infectious diseases, vital R&D activities, and the solid commercialization of organoid models. Enhanced funding and grants for organoid development contribute markedly to the thriving market in the region. The research publication accentuates the efforts of key industry players, including innovators and technology leaders that contribute to the organoids market landscape. These stakeholders drive forward the organoids sector, ensuring its steady growth and facilitating advancements in personalized medicine, drug discovery, and regenerative therapies. With a comprehensive analysis of the current trends, drivers, and barriers, the latest research publication on the North America organoids market offers an indispensable resource for understanding the market's trajectory and preparing for the upcoming developments that are set to redefine the organoids landscape by 2030. Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/r/4m8mhx About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets For E.S.T Office Hours Call +1-917-300-0470 U.S. Fax: 646-607-1907 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |